← Eichor
Condition: Recurrent Brain Metastases Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Recurrent Brain Metastases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · 590 location(s) · SWOG Cancer Research Network · NCT03418961Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Phase 1/Phase 2 · 27 location(s) · Institut de Recherches Internationales Servier · NCT05786924i-NEED: NEw migrainE Drugs Database
Phase N/A · 2 location(s) · IRCCS San Raffaele Roma · NCT07103694Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis
NA · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT07339085Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT02754544Advanced Diffusion MRI to Differentiate Tumor Recurrence From Pseudoprogression in Patients With Glioblastoma and Brain
NA · 1 location(s) · University Hospital, Basel, Switzerland · NCT05911230Imaging Features for the Risks for Recurrence After Stereotactic Radiosurgery in Brain Metastasis
Phase N/A · 1 location(s) · Asan Medical Center · NCT05868928Palbociclib and Pembrolizumab In Central Nervous System Metastases
Phase 2 · 2 location(s) · Massachusetts General Hospital · NCT028963353'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Phase N/A · 1 location(s) · Barbara Ann Karmanos Cancer Institute · NCT00935090Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin
Phase 2 · 1 location(s) · Ayal A. Aizer, MD · NCT07132190A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Pat
EARLY_Phase 1 · 1 location(s) · Nader Sanai · NCT07268053Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippo
Phase 3 · 231 location(s) · NRG Oncology · NCT04804644REMASTer: REcurrent Brain Metastases After SRS Trial
NA · 9 location(s) · Monteris Medical · NCT05124912Identification of Risk Factors for Brain Recurrence in Patients With HER2-positive Localised Breast Cancer
Phase N/A · 1 location(s) · Center Eugene Marquis · NCT06358625SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET)
NA · 6 location(s) · A.O.U. Città della Salute e della Scienza · NCT05689619A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
Phase 1/Phase 2 · 10 location(s) · Eikon Therapeutics · NCT06907043Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Phase N/A · 54 location(s) · GT Medical Technologies, Inc. · NCT04427384Early [18F]-FDG PET Dynamic Analysis in Brain Metastases After Radiotherapy.
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT07632092Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastas
Phase 2 · 1 location(s) · Ayal A. Aizer, MD · NCT07130786HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Phase 1 · 3 location(s) · M.D. Anderson Cancer Center · NCT03911388A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central
Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07698899CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
Phase 1/Phase 2 · 35 location(s) · Children's Oncology Group · NCT04870944Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR Be
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT07053033Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
Phase 2 · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT06058988Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
Phase 2 · 2 location(s) · Brigham and Women's Hospital · NCT04899908
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.